Home
IRTC
IRTC News

Latest iRhythm Technologies Inc. (IRTC) News on May 9, 2025

Veracyte Stock Earns Relative Strength Rating Upgrade

Investor's Business Daily

2 days ago

Veracyte Stock Earns Relative Strength Rating Upgrade

Progyny Stock Sees RS Rating Improve To 73

Investor's Business Daily

3 days ago

Progyny Stock Sees RS Rating Improve To 73

Masimo (MASI) Q1 Earnings Report Preview: What To Look For

StockStory

4 days ago

Masimo (MASI) Q1 Earnings Report Preview: What To Look For

iRhythm Technologies First Quarter 2025 Earnings: Beats Expectations

Simply Wall St.

6 days ago

iRhythm Technologies First Quarter 2025 Earnings: Beats Expectations

MT Newswires

7 days ago

Update: IRhythm Technologies Shares Jump After Q1 Revenue Beat

MT Newswires

7 days ago

Wells Fargo Upgrades iRhythm Technologies to Overweight, Price Target is $130

MT Newswires

7 days ago

IRhythm Technologies Q1 Adjusted Loss Narrows, Revenue Rises; 2025 Sales Guidance Raised

iRhythm Technologies Inc (IRTC) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amidst ...

GuruFocus.com

7 days ago

iRhythm Technologies Inc (IRTC) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amidst ...

IRhythm Technologies (IRTC) Reports Q1 Loss, Tops Revenue Estimates

Zacks

7 days ago

IRhythm Technologies (IRTC) Reports Q1 Loss, Tops Revenue Estimates

iRhythm (NASDAQ:IRTC) Surprises With Strong Q1, Full-Year Sales Guidance is Optimistic

StockStory

7 days ago

iRhythm (NASDAQ:IRTC) Surprises With Strong Q1, Full-Year Sales Guidance is Optimistic

iRhythm Launches Zio® Long-Term Continuous Monitoring Service in Japan as the Zio® ECG Recording and Analysis System, Advancing AI-Powered Arrhythmia Detection

GlobeNewswire

7 days ago

iRhythm Launches Zio® Long-Term Continuous Monitoring Service in Japan as the Zio® ECG Recording and Analysis System, Advancing AI-Powered Arrhythmia Detection

iRhythm Technologies Announces First Quarter 2025 Financial Results

GlobeNewswire

7 days ago

iRhythm Technologies Announces First Quarter 2025 Financial Results

iRhythm Earnings: What To Look For From IRTC

StockStory

9 days ago

iRhythm Earnings: What To Look For From IRTC

iRhythm Technologies to Present at the Bank of America Securities 2025 Health Care Conference

GlobeNewswire

9 days ago

iRhythm Technologies to Present at the Bank of America Securities 2025 Health Care Conference

MT Newswires

11 days ago

iRhythm Technologies Says Zio LTCM Shows 'Highest Diagnostic Yield' Vs Other Devices

iRhythm Presents New Real-World Data on Ambulatory Cardiac Monitoring at HRS 2025 Reinforcing Clinical Superiority of Zio Long-Term Continuous Monitoring

GlobeNewswire

11 days ago

iRhythm Presents New Real-World Data on Ambulatory Cardiac Monitoring at HRS 2025 Reinforcing Clinical Superiority of Zio Long-Term Continuous Monitoring

iRhythm Technologies to Report First Quarter 2025 Financial Results on May 1, 2025

GlobeNewswire

21 days ago

iRhythm Technologies to Report First Quarter 2025 Financial Results on May 1, 2025

iRhythm Technologies Releases 2024 Corporate Sustainability Report That Demonstrates Ongoing Commitment to Culture of Quality and Sustainability

GlobeNewswire

23 days ago

iRhythm Technologies Releases 2024 Corporate Sustainability Report That Demonstrates Ongoing Commitment to Culture of Quality and Sustainability

MT Newswires

a month ago

Truist Cuts Price Target on iRhythm Technologies to $120 From $145, Keeps Buy Rating

3 Reasons IRTC is Risky and 1 Stock to Buy Instead

StockStory

a month ago

3 Reasons IRTC is Risky and 1 Stock to Buy Instead

Q4 Patient Monitoring Earnings Review: First Prize Goes to Masimo (NASDAQ:MASI)

StockStory

a month ago

Q4 Patient Monitoring Earnings Review: First Prize Goes to Masimo (NASDAQ:MASI)

1 Small-Cap Stock Worth Your Attention and 2 to Question

StockStory

a month ago

1 Small-Cap Stock Worth Your Attention and 2 to Question

When Will iRhythm Technologies, Inc. (NASDAQ:IRTC) Turn A Profit?

Simply Wall St.

a month ago

When Will iRhythm Technologies, Inc. (NASDAQ:IRTC) Turn A Profit?

Q4 Earnings Highlights: iRhythm (NASDAQ:IRTC) Vs The Rest Of The Patient Monitoring Stocks

StockStory

a month ago

Q4 Earnings Highlights: iRhythm (NASDAQ:IRTC) Vs The Rest Of The Patient Monitoring Stocks

iRhythm Unveils New Real-World Data at ACC.25 Demonstrating the Benefits of Zio® Long-Term Continuous Monitoring for Arrhythmia Detection

GlobeNewswire

a month ago

iRhythm Unveils New Real-World Data at ACC.25 Demonstrating the Benefits of Zio® Long-Term Continuous Monitoring for Arrhythmia Detection

3 Healthcare Stocks in the Doghouse

StockStory

a month ago

3 Healthcare Stocks in the Doghouse

Patient Monitoring Stocks Q4 In Review: Insulet (NASDAQ:PODD) Vs Peers

StockStory

2 months ago

Patient Monitoring Stocks Q4 In Review: Insulet (NASDAQ:PODD) Vs Peers

iRhythm Technologies (IRTC) Upgraded to Buy: Here's What You Should Know

Zacks

2 months ago

iRhythm Technologies (IRTC) Upgraded to Buy: Here's What You Should Know

Patient Monitoring Stocks Q4 Results: Benchmarking ResMed (NYSE:RMD)

StockStory

2 months ago

Patient Monitoring Stocks Q4 Results: Benchmarking ResMed (NYSE:RMD)

1 Growth Stock to Target This Week and 2 to Ignore

StockStory

2 months ago

1 Growth Stock to Target This Week and 2 to Ignore

MT Newswires

2 months ago

Irhythm Technologies Insider Sold Shares Worth $299,770, According to a Recent SEC Filing

MT Newswires

2 months ago

Irhythm Technologies Insider Sold Shares Worth $334,468, According to a Recent SEC Filing

MT Newswires

2 months ago

Irhythm Technologies Insider Sold Shares Worth $1,538,218, According to a Recent SEC Filing

MT Newswires

2 months ago

Irhythm Technologies Insider Sold Shares Worth $281,671, According to a Recent SEC Filing

MT Newswires

2 months ago

Irhythm Technologies Insider Sold Shares Worth $2,495,117, According to a Recent SEC Filing

MT Newswires

2 months ago

Irhythm Technologies Insider Sold Shares Worth $1,791,041, According to a Recent SEC Filing

iRhythm Technologies Full Year 2024 Earnings: Beats Expectations

Simply Wall St.

3 months ago

iRhythm Technologies Full Year 2024 Earnings: Beats Expectations

MT Newswires

3 months ago

Truist Adjusts iRhythm Technologies' Price Target to $145 From $111, Keeps Buy Rating

MT Newswires

3 months ago

Oppenheimer Adjusts iRhythm Technologies Price Target to $130 From $120, Maintains Outperform Rating

MT Newswires

3 months ago

Morgan Stanley Raises Price Target on iRhythm Technologies to $130 From $95, Keeps Overweight Rating

iRhythm Technologies Inc (IRTC) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ...

GuruFocus.com

3 months ago

iRhythm Technologies Inc (IRTC) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ...

VitalConnect raises $100M for heart monitor patch

MedTech Dive

3 months ago

VitalConnect raises $100M for heart monitor patch

iRhythm (NASDAQ:IRTC) Reports Strong Q4, Stock Soars

StockStory

3 months ago

iRhythm (NASDAQ:IRTC) Reports Strong Q4, Stock Soars

IRhythm Technologies (IRTC) Beats Q4 Earnings and Revenue Estimates

Zacks

3 months ago

IRhythm Technologies (IRTC) Beats Q4 Earnings and Revenue Estimates

MT Newswires

3 months ago

iRhythm Technologies Swings to Q4 Profit, Revenue Increases; 2025 Outlook Set -- Shares Rise After Hours

iRhythm Technologies Announces Fourth Quarter and Full Year 2024 Financial Results

GlobeNewswire

3 months ago

iRhythm Technologies Announces Fourth Quarter and Full Year 2024 Financial Results

iRhythm (IRTC) To Report Earnings Tomorrow: Here Is What To Expect

StockStory

3 months ago

iRhythm (IRTC) To Report Earnings Tomorrow: Here Is What To Expect

Will iRhythm Technologies (IRTC) Report Negative Earnings Next Week? What You Should Know

Zacks

3 months ago

Will iRhythm Technologies (IRTC) Report Negative Earnings Next Week? What You Should Know

A Look At The Fair Value Of iRhythm Technologies, Inc. (NASDAQ:IRTC)

Simply Wall St.

3 months ago

A Look At The Fair Value Of iRhythm Technologies, Inc. (NASDAQ:IRTC)

iRhythm Technologies to Report Fourth Quarter and Full Year 2024 Financial Results on February 20, 2025

GlobeNewswire

3 months ago

iRhythm Technologies to Report Fourth Quarter and Full Year 2024 Financial Results on February 20, 2025

Is It Too Late To Consider Buying iRhythm Technologies, Inc. (NASDAQ:IRTC)?

Simply Wall St.

4 months ago

Is It Too Late To Consider Buying iRhythm Technologies, Inc. (NASDAQ:IRTC)?

iRhythm price target raised to $125 from $112 at Needham

TipRanks

4 months ago

iRhythm price target raised to $125 from $112 at Needham

iRhythm Technologies Reports Strong Growth and Innovation

TipRanks

4 months ago

iRhythm Technologies Reports Strong Growth and Innovation

iRhythm Technologies Shares Preliminary Fourth Quarter 2024 Highlights and Business Update at the 43rd Annual J.P. Morgan Healthcare Conference

GlobeNewswire

4 months ago

iRhythm Technologies Shares Preliminary Fourth Quarter 2024 Highlights and Business Update at the 43rd Annual J.P. Morgan Healthcare Conference

3 Undervalued US Stocks Estimated To Be Up To 30.8% Below Intrinsic Value

Simply Wall St.

4 months ago

3 Undervalued US Stocks Estimated To Be Up To 30.8% Below Intrinsic Value

iRhythm Technologies to Present at the 43rd Annual J.P. Morgan Healthcare Conference

GlobeNewswire

4 months ago

iRhythm Technologies to Present at the 43rd Annual J.P. Morgan Healthcare Conference

iRhythm price target raised to $111 from $85 at Truist

TipRanks

5 months ago

iRhythm price target raised to $111 from $85 at Truist

MT Newswires

5 months ago

Truist Securities Adjusts Price Target on iRhythm Technologies to $111 From $85, Keeps Buy Rating

MT Newswires

5 months ago

Wells Fargo Downgrades iRhythm Technologies to Equalweight, Price Target is $86

iRhythm Technologies to Participate in the Citi 2024 Global Healthcare Conference

GlobeNewswire

6 months ago

iRhythm Technologies to Participate in the Citi 2024 Global Healthcare Conference

Inside a $400 billion bet on the brain-computer interface revolution

Yahoo Finance

6 months ago

Inside a $400 billion bet on the brain-computer interface revolution

iRhythm Data Presented at the American Heart Association 2024 Scientific Sessions Reinforce Clinical and Health Economic Value of Zio Long-Term Continuous Monitoring

GlobeNewswire

6 months ago

iRhythm Data Presented at the American Heart Association 2024 Scientific Sessions Reinforce Clinical and Health Economic Value of Zio Long-Term Continuous Monitoring

Argus Research

6 months ago

Daily – Vickers Top Buyers & Sellers for 11/06/2024

iRhythm Technologies to Participate in the Wolfe Research 2024 Healthcare Conference

GlobeNewswire

6 months ago

iRhythm Technologies to Participate in the Wolfe Research 2024 Healthcare Conference

Here’s Why iRhythm Technologies (IRTC) Slid in Q3

Insider Monkey

6 months ago

Here’s Why iRhythm Technologies (IRTC) Slid in Q3

iRhythm Technologies, Inc. (NASDAQ:IRTC) Just Reported, And Analysts Assigned A US$101 Price Target

Simply Wall St.

6 months ago

iRhythm Technologies, Inc. (NASDAQ:IRTC) Just Reported, And Analysts Assigned A US$101 Price Target

FDA clears iRhythm’s second 510(k) in response to warning letter

MedTech Dive

6 months ago

FDA clears iRhythm’s second 510(k) in response to warning letter

iRhythm Technologies Inc (IRTC) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid ...

GuruFocus.com

6 months ago

iRhythm Technologies Inc (IRTC) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid ...

IRhythm Technologies (IRTC) Reports Q3 Loss, Tops Revenue Estimates

Zacks

6 months ago

IRhythm Technologies (IRTC) Reports Q3 Loss, Tops Revenue Estimates

iRhythm Technologies Receives FDA 510(k) Clearance for Design Modifications to Its Zio® AT Device

GlobeNewswire

6 months ago

iRhythm Technologies Receives FDA 510(k) Clearance for Design Modifications to Its Zio® AT Device

iRhythm Technologies Announces Third Quarter 2024 Financial Results

GlobeNewswire

6 months ago

iRhythm Technologies Announces Third Quarter 2024 Financial Results

Newly Published Research Shows 14-Day Monitoring Detected Almost Three Times More Nonsustained Ventricular Tachycardia Than Standard 48-Hour Monitoring in Patients with Hypertrophic Cardiomyopathy

GlobeNewswire

6 months ago

Newly Published Research Shows 14-Day Monitoring Detected Almost Three Times More Nonsustained Ventricular Tachycardia Than Standard 48-Hour Monitoring in Patients with Hypertrophic Cardiomyopathy

iRhythm Technologies (IRTC) Soars 21.7%: Is Further Upside Left in the Stock?

Zacks

7 months ago

iRhythm Technologies (IRTC) Soars 21.7%: Is Further Upside Left in the Stock?

iRhythm’s Zio AT design changes win FDA clearance

MedTech Dive

7 months ago

iRhythm’s Zio AT design changes win FDA clearance

With FDA Approval iRhythm May Be Able To Lift Regulatory Overhang, Investor Skepticism, Analyst Says

Benzinga

7 months ago

With FDA Approval iRhythm May Be Able To Lift Regulatory Overhang, Investor Skepticism, Analyst Says

iRhythm's Stock Skyrockets 17% After Game-Changing FDA Approval -- Is This Just the Beginning?

GuruFocus.com

7 months ago

iRhythm's Stock Skyrockets 17% After Game-Changing FDA Approval -- Is This Just the Beginning?

iRhythm Technologies Stock Rises Post FDA Clearance for Zio AT

Zacks

7 months ago

iRhythm Technologies Stock Rises Post FDA Clearance for Zio AT

Investing.com

7 months ago

iRhythm shares soar after FDA clears Zio AT device updates

MT Newswires

7 months ago

Truist Raises Price Target on iRhythm Technologies to $95 From $80, Keeps Buy Rating

iRhythm secures 510(k) clearance for Zio device updates after FDA warning

Medical Device Network

7 months ago

iRhythm secures 510(k) clearance for Zio device updates after FDA warning

MT Newswires

7 months ago

IRhythm Gets FDA Clearance for Design Updates Made to Zio AT Device; Shares Rise After-Hours

iRhythm Technologies Receives FDA 510(k) Clearance for Design Updates Previously Made to Its Zio® AT Device

GlobeNewswire

7 months ago

iRhythm Technologies Receives FDA 510(k) Clearance for Design Updates Previously Made to Its Zio® AT Device

iRhythm Technologies to Report Third Quarter 2024 Financial Results on October 30, 2024

GlobeNewswire

7 months ago

iRhythm Technologies to Report Third Quarter 2024 Financial Results on October 30, 2024

iRhythm Technologies (IRTC) Slipped on Regulatory Issues

Insider Monkey

7 months ago

iRhythm Technologies (IRTC) Slipped on Regulatory Issues

MT Newswires

7 months ago

Truist Cuts Price Target on iRhythm Technologies to $80 From $117, Keeps Buy Rating

Irhythm Technologies Outlines Growth and Market Leadership Strategy

TipRanks

7 months ago

Irhythm Technologies Outlines Growth and Market Leadership Strategy

iRhythm's Zio ECG System Gets Approval in Japan, Stock Falls

Zacks

8 months ago

iRhythm's Zio ECG System Gets Approval in Japan, Stock Falls

iRhythm’s Zio ECG monitoring system secures Japanese regulatory approval

Medical Device Network

8 months ago

iRhythm’s Zio ECG monitoring system secures Japanese regulatory approval

MT Newswires

8 months ago

iRhythm Technologies Secures Japanese Approval for EGC Monitoring Device

iRhythm Technologies Announces Japanese Regulatory Approval of the Zio® ECG Monitoring System, the First Product to Deliver Arrhythmia Monitoring Service Utilizing Artificial Intelligence

GlobeNewswire

8 months ago

iRhythm Technologies Announces Japanese Regulatory Approval of the Zio® ECG Monitoring System, the First Product to Deliver Arrhythmia Monitoring Service Utilizing Artificial Intelligence

iRhythm Stock Gains Following Favorable Zio Monitor Study Data

Zacks

8 months ago

iRhythm Stock Gains Following Favorable Zio Monitor Study Data

iRhythm Stock May Gain on Its Latest Deal With BioIntelliSense

Zacks

8 months ago

iRhythm Stock May Gain on Its Latest Deal With BioIntelliSense

iRhythm Unveils Data Demonstrating Superior Real-World Performance of Next-Generation Zio® Monitor at HRX 2024 Meeting

GlobeNewswire

8 months ago

iRhythm Unveils Data Demonstrating Superior Real-World Performance of Next-Generation Zio® Monitor at HRX 2024 Meeting

MT Newswires

8 months ago

iRhythm Technologies Signs License Agreement With BioIntelliSense for Multiparameter Sensor Technology

iRhythm Technologies Enters License Agreement with BioIntelliSense for Multiparameter Sensor Technology to be Used in Ambulatory Cardiac Monitoring

GlobeNewswire

8 months ago

iRhythm Technologies Enters License Agreement with BioIntelliSense for Multiparameter Sensor Technology to be Used in Ambulatory Cardiac Monitoring

iRhythm’s Wearable Monitor Found Heart Arrhythmias. It Didn’t Stop Strokes.

Barrons.com

8 months ago

iRhythm’s Wearable Monitor Found Heart Arrhythmias. It Didn’t Stop Strokes.

iRhythm Technologies Announces Results of GUARD-AF Trial

GlobeNewswire

8 months ago

iRhythm Technologies Announces Results of GUARD-AF Trial

iRhythm Technologies Launches Zio Monitoring Across Europe

Zacks

8 months ago

iRhythm Technologies Launches Zio Monitoring Across Europe

MT Newswires

8 months ago

iRhythm Technologies Commercially Rolls out Zio Monitor, Zio LTCM ECG Service in Four European Countries

iRhythm Technologies Expands Global Reach with the Launch of Zio® Cardiac Arrhythmia Monitoring Service in Austria, the Netherlands, Switzerland, and Spain

GlobeNewswire

8 months ago

iRhythm Technologies Expands Global Reach with the Launch of Zio® Cardiac Arrhythmia Monitoring Service in Austria, the Netherlands, Switzerland, and Spain

Share on Social Networks: